69 related articles for article (PubMed ID: 11717653)
1. Biodegradable microspheres containing group B Streptococcus vaccine: immune response in mice.
Hunter SK; Andracki ME; Krieg AM
Am J Obstet Gynecol; 2001 Nov; 185(5):1174-9. PubMed ID: 11717653
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII.
Paoletti LC; Pinel J; Johnson KD; Reinap B; Ross RA; Kasper DL
J Infect Dis; 1999 Sep; 180(3):892-5. PubMed ID: 10438388
[TBL] [Abstract][Full Text] [Related]
3. Protective immunization in mice against group B streptococci using encapsulated C5a peptidase.
Santillan DA; Andracki ME; Hunter SK
Am J Obstet Gynecol; 2008 Jan; 198(1):114.e1-6. PubMed ID: 17905172
[TBL] [Abstract][Full Text] [Related]
4. Pluronic F127 enhances the effect as an adjuvant of chitosan microspheres in the intranasal delivery of Bordetella bronchiseptica antigens containing dermonecrotoxin.
Kang ML; Jiang HL; Kang SG; Guo DD; Lee DY; Cho CS; Yoo HS
Vaccine; 2007 Jun; 25(23):4602-10. PubMed ID: 17485148
[TBL] [Abstract][Full Text] [Related]
5. Conjugate vaccines against group B Streptococcus types IV and VII.
Paoletti LC; Kasper DL
J Infect Dis; 2002 Jul; 186(1):123-6. PubMed ID: 12089673
[TBL] [Abstract][Full Text] [Related]
6. Immunization of pregnant women with a polysaccharide vaccine of group B streptococcus.
Baker CJ; Rench MA; Edwards MS; Carpenter RJ; Hays BM; Kasper DL
N Engl J Med; 1988 Nov; 319(18):1180-5. PubMed ID: 3050524
[TBL] [Abstract][Full Text] [Related]
7. Intranasal immunization with GBS surface protein Sip and ScpB induces specific mucosal and systemic immune responses in mice.
Xue G; Yu L; Li S; Shen X
FEMS Immunol Med Microbiol; 2010 Mar; 58(2):202-10. PubMed ID: 19912341
[TBL] [Abstract][Full Text] [Related]
8. Naturally occurring antibodies for the group B streptococcal surface immunogenic protein (Sip) in pregnant women and newborn babies.
Manning SD; Wood S; Kasha K; Martin D; Rioux S; Brodeur B; Davies HD
Vaccine; 2006 Nov; 24(47-48):6905-12. PubMed ID: 16844270
[TBL] [Abstract][Full Text] [Related]
9. [What is the purpose of mucosal antibodies? Relevance to colonization with group B streptococci].
Hordnes K; Jonsson R; Brandtzaeg P; Haneberg B
Tidsskr Nor Laegeforen; 1997 Nov; 117(28):4109-13. PubMed ID: 9441448
[TBL] [Abstract][Full Text] [Related]
10. Strong mucosal adjuvanticity of cholera toxin within lipid particles of a new multiple emulsion delivery system for oral immunization.
Tomasi M; Dertzbaugh MT; Hearn T; Hunter RL; Elson CO
Eur J Immunol; 1997 Oct; 27(10):2720-5. PubMed ID: 9368632
[TBL] [Abstract][Full Text] [Related]
11. Immunogenicity of polysaccharides from type III, group B Streptococcus.
Baker CJ; Edwards MS; Kasper DL
J Clin Invest; 1978 Apr; 61(4):1107-10. PubMed ID: 96132
[TBL] [Abstract][Full Text] [Related]
12. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
[TBL] [Abstract][Full Text] [Related]
13. Bovine antibody against Streptococcus agalactiae, type Ia, produced by preparturient intramammary and systemic vaccination.
Yokomizo Y; Norcross NL
Am J Vet Res; 1978 Mar; 39(3):511-6. PubMed ID: 345893
[TBL] [Abstract][Full Text] [Related]
14. Intranasal immunization of mice with group B streptococcal protein rib and cholera toxin B subunit confers protection against lethal infection.
Larsson C; Holmgren J; Lindahl G; Bergquist C
Infect Immun; 2004 Feb; 72(2):1184-7. PubMed ID: 14742572
[TBL] [Abstract][Full Text] [Related]
15. Antibody response in lacteal secretions of cows after immunization with various concentrations of staphylococcal and streptococcal antigens.
Opdebeeck JP; Norcross NL
Am J Vet Res; 1982 Oct; 43(10):1770-5. PubMed ID: 6756223
[TBL] [Abstract][Full Text] [Related]
16. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women.
Baker CJ; Paoletti LC; Rench MA; Guttormsen HK; Carey VJ; Hickman ME; Kasper DL
J Infect Dis; 2000 Oct; 182(4):1129-38. PubMed ID: 10979909
[TBL] [Abstract][Full Text] [Related]
17. Poly(lactide-co-glycolide) microencapsulation of vaccine antigens.
Jones DH; McBride BW; Farrar GH
J Biotechnol; 1996 Jan; 44(1-3):29-36. PubMed ID: 8717383
[TBL] [Abstract][Full Text] [Related]
18. [Stimulation of synthesis of secretory immunoglobulin A in the lung by oral immunization: an approach with therapeutic relevance?].
Kofler N; Wolf H
Wien Klin Wochenschr; 1996; 108(14):432-7. PubMed ID: 8928514
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib.
Baker CJ; Paoletti LC; Wessels MR; Guttormsen HK; Rench MA; Hickman ME; Kasper DL
J Infect Dis; 1999 Jan; 179(1):142-50. PubMed ID: 9841833
[TBL] [Abstract][Full Text] [Related]
20. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
Baker CJ; Rench MA; Kasper DL
N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
